Atlas Trials

A Study of the Systemic Absorption of MOB015B

Clinical trial NCT03244280 · COMPLETED

Trial details

NCT number
NCT03244280
Sponsor
Moberg Pharma AB
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Onychomycosis
Start date
2017-12-16
Primary completion
2018-04-23
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.